Detalhe da pesquisa
1.
Drug survival and clinical effectiveness of secukinumab, ixekizumab, brodalumab, guselkumab, risankizumab, tildrakizumab for psoriasis treatment.
J Dtsch Dermatol Ges
; 22(1): 34-42, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37926830
2.
Comparison between brodalumab, secukinumab and ixekizumab effectiveness and drug survival: A real-life experience on 638 patients with psoriasis.
Exp Dermatol
; 32(9): 1591-1594, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37395012
3.
"Superresponders" at biologic treatment for psoriasis: A comparative study among IL17 and IL23 inhibitors.
Exp Dermatol
; 32(12): 2187-2188, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36541075
4.
Drug survival and efficacy of anti-interleukin 23 biologics in psoriasis: a comparative study on different agents.
Clin Exp Dermatol
; 48(4): 379-381, 2023 03 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-36745578
5.
Tildrakizumab in real-life shows good efficacy in moderate-to-severe psoriasis regardless of previous use of biologic drugs and joint involvement.
Dermatol Ther
; 35(11): e15818, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36097346
6.
Efficacy of switching from adalimumab originator to adalimumab biosimilar in moderate to severe psoriasis patients: A Real-life experience in a tertiary referral centre.
Australas J Dermatol
; 62(3): e431-e432, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34042171
7.
Drug survival, effectiveness, and safety of brodalumab for moderate-to-severe psoriasis up to 3 years.
Int J Dermatol
; 2024 Jan 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38284277
8.
Clinical characteristics and response to biological therapies for inverse psoriasis: a real-life comparison between the therapeutic effects of anti-IL-23 and anti-IL-17 agents.
Int J Dermatol
; 2024 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38751026
9.
Interclass Switch between IL17 and IL23 Inhibitors in Psoriasis: A Real-Life, Long-Term, Single-Center Experience.
J Clin Med
; 12(24)2023 Dec 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38137572
10.
Clinical effectiveness of IL-17 and IL-23 inhibitors on difficult-to-treat psoriasis areas (scalp, genital, and palmoplantar sites): a retrospective, observational, single-center, real-life study.
Expert Opin Biol Ther
; 23(9): 929-936, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37458181
11.
Efficacy, safety, and drug survival of IL-23, IL-17, and TNF-alpha inhibitors for psoriasis treatment: a retrospective study.
J Dermatolog Treat
; 33(4): 2352-2357, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-34315331
12.
Gender differences in genital lichen sclerosus: data from a multicenter Italian study on 729 consecutive cases.
G Ital Dermatol Venereol
; 155(2): 155-160, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-29368855
13.
O6-methylguanine-DNA methyltransferase promoter hypermethylation in colorectal carcinogenesis.
Oncol Rep
; 17(6): 1421-7, 2007 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-17487400
14.
Fatty liver, carotid disease and gallstones: a study of age-related associations.
World J Gastroenterol
; 12(36): 5826-33, 2006 Sep 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-17007049
15.
Is nonalcoholic steatohepatitis associated with a high-though-normal thyroid stimulating hormone level and lower cholesterol levels?
Intern Emerg Med
; 8(4): 297-305, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21559749
16.
Non-organ-specific autoantibodies in nonalcoholic fatty liver disease: prevalence and correlates.
Dig Dis Sci
; 48(11): 2173-81, 2003 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-14705824